Bubs Australia hits 4-month high on solid quarterly sales in US
18/03/2024 24:51
** Shares of Bubs Australia BUB.AX rise as much as 14.8%
to A$0.155, their highest since Nov 21, 2023
** The food processing firm says U.S. quarterly sales of its
infant formula product Scan grew 161% year-on-year
** Co says it remained confident to be cash-flow positive
and trading EBIT positive in FY25
** BUB stock up ~4% YTD, as of last close
(Reporting by Ayushman Ojha in Bengaluru)
((Ayushman.ojha@thomsonreuters.com;))
Recent news on Bubs Australia
See all newsBubs Australia hits near two-month low as quarterly revenue declines
Bubs Australia shares set for 15% weekly gain on FDA approval for infant formula products
Bubs Australia extends rally after infant formulas get US FDA approval
Bubs Australia gets permanent FDA nod for infant formula sales in US, shares jump (updated)
Bubs Australia secures permanent FDA nod for infant formula sales in US, shares jump